Adani Group founder Gautam Adani is once again Asia’s richest person 

Adani Group founder Gautam Adani is once again Asia’s richest person 

Gautam Adani is the richest person in Asia again, according to Bloomberg Billionaires Index’s updated figures Friday.  The founder and chairman of the Adani Group regained pole position in Asia after dethroning Reliance Industries Chairman Mukesh Ambani, who took the top spot after Hindenburg Research accused the Adani Group of “brazen stock manipulation and accounting…

Packers accomplish historic feat as they clinch playoff berth

Packers accomplish historic feat as they clinch playoff berth

Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…

Newell Brands to Cut 7% of Office Roles, Reduce Footprint

Newell Brands to Cut 7% of Office Roles, Reduce Footprint

Newell Brands will slash about 7% of its office roles and pare down its real-estate footprint in an organizational realignment. The Atlanta-based maker of Rubbermaid and Sharpie said it expected to realize annual pretax savings of $65 million to $90 million net of reinvestment, the majority of which is expected this year. Copyright ©2024 Dow…

Nvidia to launch China-focused AI chip in Q2 2024, sources say

Nvidia to launch China-focused AI chip in Q2 2024, sources say

Microchip and Nvidia logo displayed on a phone screen are seen in this multiple exposure illustration photo taken in Krakow, Poland on April 10, 2023. Nurphoto | Getty Images U.S. chipmaker Nvidia plans to begin mass production in the second quarter of 2024 of an artificial intelligence (AI) chip it designed for China to comply…

SEC commissioner laments backlash over CFP committee’s exclusion of Florida State

SEC commissioner laments backlash over CFP committee’s exclusion of Florida State

Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…

Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion

Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx for $28 each was expected have a value of $1.9 billion net of estimated cash required. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved….